Michelle Williams
Psychiatric/Mental Health · Columbia, MDNPI 1912151531
Payments from drug & device makers
Across 1,559 payments — averaging $101.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$53K
- Axsome Therapeutics, Inc.$36K
- Otsuka America Pharmaceutical, Inc.$33K
- Neurocrine Biosciences, Inc.$16K
- Lundbeck LLC$2K
- Teva Pharmaceuticals USA, Inc.$2K
- plus $15K from 46 others
What the payments were for
- Consulting fees$21,46514%
- Speaking & faculty fees$105,04766%
- Travel & lodging$2,9402%
- Food & beverage$28,46018%
- Education$2730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$158,183 in reported general payments places this provider in the 95th percentile of 1,461 psychiatric/mental health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 41 | $484,496 |
| IngrezzaValbenazine Tosylate | 24 | $196,131 |
| VraylarCariprazine Hcl | 33 | $76,829 |
| Abilify MaintenaAripiprazole | 21 | $60,067 |
| CaplytaLumateperone Tosylate | 20 | $45,710 |
| AuvelityDextromethorphan Hbr/Bupropion | 32 | $37,339 |
| QelbreeViloxazine Hcl | 14 | $13,858 |
| VyvanseLisdexamfetamine Dimesylate | 32 | $13,842 |
| Duloxetine Hcl | 212 | $7,153 |
| Bupropion XlBupropion Hcl | 168 | $6,881 |
| Lisdexamfetamine Dimesylate | 27 | $6,796 |
| Quetiapine Fumarate | 214 | $5,860 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 41 | $5,716 |
| QuviviqDaridorexant Hcl | 11 | $4,808 |
| Divalproex Sodium ErDivalproex Sodium | 48 | $4,564 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $1,952 | $484,49641 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $16,450 | $196,13124 claims |
| AbbVieVraylar | $53,279 | $76,82933 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $33,060 | $60,06721 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,943 | $45,71020 claims |
| Axsome Therapeutics, Inc.Auvelity | $35,994 | $37,33932 claims |
| Supernus Pharmaceuticals, Inc.Qelbree | $791 | $13,85814 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $554 | $13,84232 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $212 | $4,80811 claims |
| Lilly USA, LLCOlanzapine | $28 | $3,54850 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,461 psychiatric/mental health providers in Maryland.
Other psychiatric/mental health in Columbia
- Zenatsehay GebretsadikColumbia$15K
- Elshaday TeferiColumbia$11K
- Benjamin DahunsiColumbia$5K
- Hara OyedejiOwings Mills$780K
- Ilya RozenbergGlen Burnie$572K
- Kristin ClemensGaithersburg$36K
- Antonio HeroldHavre de Grace$23K
- Paul KlaverweidenFruitland$17K
- Margaret WebbAberdeen$16K
- Susan KrausTowson$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.